This episode is for supporters only. Every other episode of Citation Needed is free, so you can tune in next week for a free one—and if you enjoy it and want access to every episode each week (that’s double the content), please consider becoming a paying subscriber. Your support helps us devote time to digging into these papers, articles, and news items so you don’t have to.
In our first segment, we tackle an article by Andrew Sinclair—the very scientist who discovered the SRY gene—slamming World Athletics for using it as the basis for sex eligibility testing in women’s sports. Sinclair asserts the policy is “misguided,” but we break down why he’s confused about the science, ignorant of the rules, and explain why testing for the SRY test is a clear, enforceable, and scientifically sound method for ensuring the integrity of female sports. Turns out, discovering the gene doesn’t make you an expert in sports policy any more than discovering fire makes you a Michelin chef!
Plus, in the second half, we wade into the world of Fat Studies—specifically, a paper fretting that the diabetes drug Ozempic is a dire threat to “the future of fatness.” Yes, that’s an actual phrase. We explore the author’s claims that weight loss drugs perpetuate “anti-fatness” and “oppressive economic structures,” examine her desire to conserve fatness like it’s the rainforest, and have some laughs along the way.
